CTRI/2019/07/020055已完成未知
asal high frequency oscillatory ventilation(nHFOV) versus non invasive positive pressure ventilation(NIPPV) as a post extubation respiratory support in preterm neonates( 26-37 weeks) admitted in a tertiary care centre â?? A randomized controlled trial
Department of Neonatology0 个研究点目标入组 86 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Infants born between 26 weeks of gestation and <= 37 weeks of gestation and birth weight between 500 grams to 2500 grams
- •2. Inborn babies upto postnatal age 15 days
- •3. Mechanically ventilated for at least 12 hrs
排除标准
- •1.Babies < 26 weeks gestational age at birth and > 37 weeks of gestation and < 500
- •2. Outborn babies
- •3. Major congenital anomalies or known/suspected chromosomal anomalies
- •4. Upper airway anomalies
- •5. Severe perinatal asphyxia ( blood gas pH less than 7.0 and BE more than -12 )
- •6. Participation in another randomized interventional trial
研究者
相似试验
尚未招募
Unknown
Comparison of two modes of ventilation NHFOV( newer entity) and NIPPV( pre existing entity) in premature babies who require respiratory support.CTRI/2023/05/053140Pt.B D Sharma University Health Sciences,
尚未招募
不适用
Comparison Of Non Invasive Ventilation In CPAP Failure Preterm Infants With Respiratory Distress As A Rescue ModeCTRI/2021/10/037681ONE
已完成
不适用
The use of high frequency oscillator ventilation (HFOV) in paediatric acute respiratory distress syndrome (ARDS) with open lung techniquePaediatic acute respiratory distress syndrome (ARDS)RespiratoryRespiratory failure, not elsewhere classifiedISRCTN19924570Rachada Pisek Somphotch (Thailand)30
已完成
3 期
asal High Frequency Oscillatory Ventilation versus Nasal Continuous Positive Airway Pressure as Initial Therapy in Respiratory Distress Syndrome in Preterm NewbornsNeonatal DiseasesRespiratoryPACTR202207646279984Tanta unversity hospital60
已完成
不适用
se of high frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity: a multicentre trialChronic lung diseaseRespiratoryISRCTN98436149Medical Research Council (MRC) (UK)800